Clinical Trial

A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn how \[14C\]ulonivirine moves through a healthy person's body over time. Researchers will study how \[14C\]ulonivirine is absorbed by the body, broken down by the body, and how it leaves the body.
Trial Details
NCT Number NCT07334886
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 8 participants
Start Date 2025-09-17
Primary Completion 2025-11-11 (estimated)
Study Completion 2025-11-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-12